The respiratory effects of volatile organic compounds

International Journal of Occupational and Environmental Health

Volumn 6, Issue 1, 2000, Pages 1-8

  Pappas, George P ^a   Herbert, Rhonda J ^b   Henderson, William ^a   Koenig, Jane ^a   Stover, Bert ^a   Barnhart, Scott ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Air pollution; Airway inflammation; Allergy; Asthma; Lung function; Volatile organic compounds

Indexed keywords

BIOCHEMICAL MARKER; VOLATILE ORGANIC COMPOUND;

ADULT; AIR POLLUTION; ALLERGY; ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LUNG FUNCTION; MALE; NORMAL HUMAN; NOSE MUCUS; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 0033950558     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2000.6.1.1     Document Type: Article

References (28)

1. Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution. Part II. Am Rev Respir Dis. 1988; 137;221-42.
2. Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution. Part I. Am Rev Respir Dis. 1987; 136:1486-508.
3. Cooke TF. Indoor air pollutants. A literature review. Rev Environ Health. 1991;9:137-60.
4. Skov P, Valbjorn O. The sick building syndrome in the office environment: the Danish town hall study. Environ Int. 1987; 13:339-49.
5. Norback D, Michel I, Widstrom J. Indoor air quality and personal factors related to the sick building syndrome. Scand J Work Environ Health. 1990; 16:121-8.
6. Norback D, Torg'en M, Edling C. Volatile organic compounds, respirable dust, and personal factors related to prevalence and incidence of sick building syndrome in primary schools. Br J Ind Med. 1990; 47:733-41.
7. Ware JH, Spengler JD, Neas LM, et al. Respiratory and irritant health effects of ambient volatile organic compounds. The Kanawha County Health Study [see comments]. Am J Epidemiol. 1993; 137:1287-301.
8. Molhave L, Moller J. The atmospheric environment in modern Danish dwellings: measurements in 39 flats. In: Valbjo POFaO (ed). Indoor Climate. Horsholm, Denmark, 1979, 171-86.
9. Molhave L. Indoor air pollution due to organic gases and vapors or solvents in building materials. Environ Int. 1982; 8:117-27.
10. Hargreave FE, Ryan G, Thomson NC, Latimer K, Juniper EF. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. Eur J Respir Dis. 1982; 121 suppl:79-88.
11. Crapo RO, Morris AH, Gardner RM. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987; 136:1285-98.
12. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981; 123 659-64.
13. Wallace LA, Pellizzari ED, Hartwell TD, et al. The TEAM (Total Exposure Assessment Methodology) study: personal exposures to toxic substances in air, drinking water, and breath of 400 residents of New Jersey, North Carolina, and North Dakota. Environ Res. 1987; 43:290-307.
14. McBride DE, Koenig JQ, Luchtel DL, Williams PV, Henderson WR Jr. Inflammatory effects of ozone in the upper airways of subjects with asthma. Am J Respir Crit Care Med. 1994; 149:1192-7.
15. Graham DE, Koren HS. Biomarkers of inflammation in ozone-exposed humans. Comparison of the nasal and bronchoalveolar lavage. Am Rev Respir Dis. 1990; 142:152-6.
16. Bascom R, Naclerio RM, Fitzgerald TK, Kagey Sobotka A, Proud D. Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects. Am Rev Respir Dis. 1990; 142:594-601.
17. Fahy JV, Liu J, Wong H, Boushey HA. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol. 1994; 93:1031-9.
18. Snedecor GW. Statistical Methods. 6th ed. Ames, IA: Iowa State University Press, 1967.
19. Hodgson M, Levin H, Wolkoff P. Volatile organic compounds and indoor air. J Allergy Clin Immunol. 1994; 94:296-303.
20. Norback D, Bjornsson E, Janson C, Widstrom J, Boman G. Asthmatic symptoms and volatile organic compounds, formaldehyde, and carbon dioxide in dwellings. Occup Environ Med. 1995; 52:388-95.
21. Wieslander G, Norback D, Edling C. Airway symptoms among house painters in relation to exposure to volatile organic compounds (VOCs) - a longitudinal study. Ann Occup Hyg. 1997; 41:155-66.
22. Wieslander G, Norback D, Bjornsson E, Janson C, Boman G. Asthma and the indoor environment: the significance of emission of formaldehyde and volatile organic compounds from newly painted indoor surfaces. Int Arch Occup Environ Health. 1997; 69:115-24
23. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med. 1995; 151:548-53.
24. Barnes PJ. Neurogenic inflammation in airways. Int Arch Allergy Appl Immunol. 199; 94:303-9.
25. Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WT, Balmes JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis. 1993; 148:1363-72.
26. Koren HS, Devlin RB. Human upper respiratory tract responses to inhaled pollutants with emphasis on nasal lavage. Ann NYAcad Sci. 1992; 641:215-24.
27. Harving H, Dahl R, Molhave L. Lung function and bronchial reactivity in asthmatics during exposure to volatile organic compounds. Am Rev Respir Dis. 1991; 143:751-4.
28. Koren HS, Graham DE, Devlin RB. Exposure of humans to a volatile organic mixture. III. Inflammatory response. Arch Environ Health. 1992; 47:39-44.